Document Report Card

Basic Information

ID: ALA1135080

Journal: Bioorg Med Chem Lett

Title: Pyridazine based inhibitors of p38 MAPK.

Authors: McIntyre CJ, Ponticello GS, Liverton NJ, O'Keefe SJ, O'Neill EA, Pang M, Schwartz CD, Claremon DA.

Abstract: Trisubstituted pyridazines were synthesized and evaluated as in vitro inhibitors of p38MAPK. The most active isomers were those possessing an aryl group alpha and a heteroaryl group beta relative to the nitrogen atom in the 2-position of the central pyridazine. Additionally, substitution in the 6-position of the central pyridazine with a variety of dialkylamino substituents afforded a set of inhibitors having good (p38 IC50 1-20 nM) in vitro activity.

CiteXplore: 11844702

DOI: 10.1016/s0960-894x(01)00834-4